MC
Mukul Chandrakant Bhise
About Mukul Chandrakant Bhise
Mukul Chandrakant Bhise has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Genrx Pharma Impex Private Limited. Formerly with 3 companies, such as Crescent Specialty Chemicals Private Limited and Akribis Advisors Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Genrx Pharma Impex Private Limited
U51397MH2011PTC213629
|
Director | 16 Feb 2011 | 2011 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Crescent Specialty Chemicals Private Limited
U24233MH2011PTC223933
|
Director | 05 Jan 2017 | 2011 | Active |
Akribis Advisors Private Limited
U74900MH2012PTC234579
|
Director | 16 Aug 2012 | 2012 | Active |
Prosperitas Solutions Private Limited
U72300MH2012PTC234610
|
Director | 17 Aug 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mukul Chandrakant Bhise
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mukul Chandrakant Bhise
Mukul Chandrakant Bhise has 15 years in corporate governance. Holds Director role. Currently with 1 company, including Genrx Pharma Impex Private Limited. Formerly with 3 companies, such as Crescent Specialty Chemicals Private Limited and Akribis Advisors Private Limited. Engaged in General Business. Contributes to corporate operations.
Mukul Chandrakant Bhise is associated with 1 company as Director.
Mukul Chandrakant Bhise has expertise in General Business.
Mukul Chandrakant Bhise has 15 years in corporate governance.